Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

This grant opportunity (PAR-25-145) from the NIH seeks proposals for clinical characterization of adverse sequelae resulting from cancer therapy and the development of mechanism-based interventional strategies. The funding opportunity is a Clinical Trial Optional R01 grant.